Artivion | CRY - Net Income

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $-2.29M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -4.41M 6.33M Feb/2025
Artivion USD -2.29M 167K Sep/2024
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Integra LifeSciences USD -5.4M 478.67M Sep/2025
J&J USD 5.12B 36M Dec/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -126M 98.61M Dec/2024
Pfizer USD -1.65B 5.19B Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 32.65B 2.4B Dec/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025